title: Comorbid conditions in men with ED before and after ED diagnosis: a retrospective database study.
abstract: Although erectile dysfunction (ED) has been considered a complication of other medical conditions, clinicians and researchers suggest that ED may serve as a clinical marker of vascular health. This retrospective claims study examined the prevalence of predefined comorbid conditions in men with ED (N=301 994) in the 12 months before and the 6 months following ED diagnosis. Consistent with previous research, comorbid conditions were prevalent among men with ED. Comorbid conditions were most often diagnosed before an ED diagnosis, although new diagnoses in the 6 months following an ED diagnosis were common and occured more frequently than new diagnoses in a matched sample of men without ED during the same period. Differences by age, region and insurance coverage for ED medications were also examined. Findings support previous research that suggests ED may serve as a marker for previously undetected comorbid conditions.
authors.affiliation: Outcomes Research, Eli Lilly and Company, Lilly Corporate Center, Drop Code 1833, Indianapolis, IN 46285, USA. cameronae@lilly.com
authors.forename: A
authors.initials: A
authors.lastname: Cameron
authors.forename: P
authors.initials: P
authors.lastname: Sun
authors.forename: M
authors.initials: M
authors.lastname: Lage
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D015897:Comorbidity; D016208:Databases, Factual; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D007348:Insurance, Health; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000191:economics / Q000627:therapeutic use; D012189:Retrospective Studies; D014481:United States / Q000453:epidemiology
chemical_list: D010726:Phosphodiesterase Inhibitors